^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

BOS-342

i
Other names: BOS-342, PRS-342, lipocalin variant, PRS 342, MPAL1073, BOS342, BOS 342, MPAL 1073, MPAL-1073, PRS342
Associations
Trials
Company:
Boston Pharma, Palvella Therapeutics
Drug class:
CD137 agonist, GPC-3 inhibitor
Related drugs:
Associations
Trials